Table 2. Demographic features of HCWs with occupational exposure to Crimean-Conger hemorrhagic fever virus, Turkey, 2004–2011*.
| Episode, outcome† | HCW age, y/sex/profession | Procedure | Transmission route | Ribavirin for postexposure prophylaxis | Ribavirin for therapy (no. d after symptom onset) | Fatal |
|---|---|---|---|---|---|---|
| Episode 1; survived, her baby died |
36/M/nurse | Wound care | Contact with surgical wound without protective equipment | No | Yes (0) | No |
| 31/F/nurse |
Intubation, aspiration |
Aerosol and droplet and contact without protective equipment |
No |
No |
No |
|
| Episode 2; died |
28/F/nurse |
Phlebotomy |
Needlestick |
No |
Yes (3) |
Yes |
| Episode 3; died |
41/M/physician | Resuscitation | Aerosol and droplet | – | Yes (0) | No |
| 26/M/physician | Nasal tamponade | Indirect contact | – | Yes (0) | No | |
| 29/M/physician |
Nasal tamponade |
Indirect contact |
– |
Yes (0) |
No |
|
| Episode 4; survived |
30/M/nurse |
Phlebotomy |
Needlestick |
No |
Yes (1) |
No |
| Episode 5; survived |
30/F/nurse |
Phlebotomy |
Needlestick |
Yes |
– |
No |
| Episode 6; survived | 24/F/physician | Phlebotomy | Needlestick | Yes | – | No |
*HCW, health care worker; –, ribavirin not necessary. †Outcome for the index case-patient in each episode.